Palbociclib-d8 is labelled Palbociclib (P139900), an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Molecular Formula: C24H21D8N7O2 Molecular Weight: 455.58 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
455.58
CAS Number:
[1628752-83-9]
* VAT and and shipping costs not included. Errors and price changes excepted